healthy Heart Africa Program expands to Tackle Chronic Kidney Disease
Table of Contents
- healthy Heart Africa Program expands to Tackle Chronic Kidney Disease
- Frequently Asked Questions
- What is the healthy Heart Africa program?
- When did the HHA program expand to include chronic kidney disease?
- How many people have been screened for high blood pressure through HHA?
- What is the program’s approach to improving healthcare?
- How does HHA work with local governments?
- What is the role of climate change in this expansion?
- Frequently Asked Questions
AstraZeneca‘s Healthy Heart Africa (HHA) program, initially launched in 2014, has broadened its scope to address the escalating rates of chronic kidney disease (CKD) across the African continent. The program originally focused on preventing and controlling hypertension and lessening the impact of cardiovascular disease.
This expansion, announced in 2024, acknowledges the increasing interconnectedness of heart and kidney health, a trend worsened by the effects of climate change on public health.
The HHA program employs a holistic strategy, aiming to enhance both health equity and the robustness of healthcare systems. It prioritizes adaptability in response to evolving environmental conditions and health challenges.
A key component of the program involves collaborative partnerships with Ministries of Health and other organizations to promote preventative measures, slow disease progression, and reduce the strain on healthcare resources.
To date, the program has screened 67.4 million individuals for high blood pressure. More than eleven thousand seven hundred health workers have also received training through HHA initiatives.
These efforts are designed to improve the early identification of cardiovascular and related conditions, enhance patient management, and increase access to essential care. The program also focuses on minimizing the environmental impact of healthcare delivery.
The initial launch of Healthy Heart Africa in 2014 represented a significant investment in addressing the growing burden of non-communicable diseases in Africa. The program’s success in hypertension screening and health worker training laid the groundwork for this latest expansion.
Non-communicable diseases, including hypertension and CKD, are a rising global health concern, especially in low- and middle-income countries.Climate change is increasingly recognized as a contributing factor,exacerbating existing health vulnerabilities and creating new ones. Integrated healthcare approaches, like that of HHA, are crucial for building resilient health systems capable of addressing these complex challenges.
Frequently Asked Questions
What is the healthy Heart Africa program?
Healthy Heart Africa (HHA) is an AstraZeneca-lead initiative focused on preventing and controlling hypertension and,now,chronic kidney disease across Africa through collaborative partnerships.
When did the HHA program expand to include chronic kidney disease?
The program expanded its focus to include chronic kidney disease in 2024, recognizing the growing prevalence of both heart and kidney ailments.
How many people have been screened for high blood pressure through HHA?
As of late 2024, HHA has screened 67.4 million people for elevated blood pressure.
What is the program’s approach to improving healthcare?
HHA takes an integrated approach, focusing on health equity, health systems resilience, and adapting to environmental changes.
How does HHA work with local governments?
HHA collaborates with Ministries of Health and other partners to promote prevention, manage disease progression, and reduce healthcare burdens.
What is the role of climate change in this expansion?
Climate change is exacerbating the prevalence of heart and kidney diseases, prompting the program to address these interconnected health challenges.